Phase II study of 5-fluorouracil and folinic acid in the treatment of patients with advanced gastric cancer. A southwest oncology group study
- 1 September 1995
- Vol. 76 (5) , 715-719
- https://doi.org/10.1002/1097-0142(19950901)76:5<715::aid-cncr2820760502>3.0.co;2-3
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Controlled evaluation of three drug combination regimens versus fluorouracil alone for the therapy of advanced gastric cancer. North Central Cancer Treatment Group.Journal of Clinical Oncology, 1994
- Sequential high-dose methotrexate and fluorouracil combined with doxorubicin--a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group.Journal of Clinical Oncology, 1991
- Review: 5-Fluorouracil cardiotoxicity: A critical reviewAnnals of Oncology, 1990
- Peripheral T-cell lymphomas have a worse prognosis than B-cell lymphomas: A prospective study of 361 immunophenotyped patients treated with the LNH-84 regimenAnnals of Oncology, 1990
- A Comparison of Three Chemotherapeutic Regimens in the Treatment of Advanced Pancreatic and Gastric CarcinomaJAMA, 1985
- Adenocarcinoma of the stomach: Review of 1,497 casesCancer, 1978
- Cytotoxicity of 5-fluoro-2'-deoxyuridine: requirement for reduced folate cofactors and antagonism by methotrexate.Proceedings of the National Academy of Sciences, 1978